A rapid cytoplasmic mechanism for pi3 kinase regulation by the nuclear thyroid hormone receptor, trβ, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo

Endocrinology (United States)

Volumn 155, Issue 9, 2014, Pages 3713-3724

  Martin, Negin P ^a   De Velasco, Ezequiel Marron Fernandez ^a   Mizuno, Fengxia ^a   Scappini, Erica L ^a   Gloss, Bernd ^a   Erxleben, Christian ^a   Williams, Jason G ^a   Stapleton, Heather M ^b   Gentile, Saverio ^a,c   Armstrong, David L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR DISTRIBUTION; CHO CELL LINE; CYTOPLASM; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPAL CA1 REGION; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; POINT MUTATION; PROTEIN FUNCTION; PROTEIN MOTIF; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SYNAPSE; THYROID HORMONE METABOLISM; ANIMAL; ARTICLE; C57BL MOUSE; CELL NUCLEUS; ENZYMOLOGY; GENETICS; HIPPOCAMPUS; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT;

LYN PROTEIN-TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA;

ANIMALS; CELL NUCLEUS; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; CYTOPLASM; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; SRC-FAMILY KINASES; SYNAPSES; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES;

EID: 84907042872     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2058     Document Type: Article

References (49)

1. Tata JR. One hundred years of hormones. EMBO Rep. 2005;6: 490-496.
2. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104:719-730.
3. Losel RM, Falkenstein E, Feuring M, et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev. 2003; 83:965-1016.
4. Hammes SR, Levin ER. Recent advances in extranuclear steroid receptor actions. Endocrinology. 2011;152:4489-4495.
5. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81:1097-1142.
6. O'Shea PJ, Williams GR. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol. 2002;175:553-570.
7. Tata JR. The road to nuclear receptors of thyroid hormone. Biochim Biophys Acta. 2013;1830:3860-3866.
8. Bassett JHD, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor specific nuclear and extranuclear actions. Mol Cell Endocrinol. 2003;213:1-11.
9. Davis PJ, Leonard JL, Davis FB. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol. 2008;29:211-218.
10. Storey NM, O'Bryan JP, Armstrong DL. Rac and Rho mediate opposing hormonal regulation of the ether-a-go-go-related potassium channel. Curr Biol. 2002;12:27-33.
11. Incerpi S, De Vito P, Luly P, Spagnuolo S, Leoni S. Short-term effects of thyroid hormones and 3, 5-diiodothyronine on membrane transport systems in chick embryo hepatocytes Endocrinology. 2002; 143:1660-1668.
12. Lei J, Mariash CN, Ingbar DH. 3, 3', 5-Triiodo-L-thyronine up-reg-ulation of Na, K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase-and phosphoinositide 3-kinase-dependent. J Biol Chem. 2004;279:47589-47600.
13. Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signaling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 2012;13: 195-203.
14. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidyl-inositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606-617.
15. Waite K, Eickholt BJ. The neurodevelopmental implications of PI3K signaling. Curr Top Microbiol Immunol. 2010;346:245-265.
16. Armstrong DL. Implications of thyroid hormone signaling through the phosphoinositide-3-kinase for xenobiotic disruption of human health. In: Gore A, ed. Endocrine Disrupting Chemicals: From Basic Research to Clinical Practice. Totowa, NJ: Humana Press; 2007: 193-202.
17. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139-170.
18. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory sub-unit of phosphatidylinositol-3-OH kinase. Nature. 2000;407:538-541.
19. Hiroi Y, Kim HH, Ying H, et al. Rapid non-genomic actions of thyroid hormone. Proc Natl Acad Sci USA. 2006;103:14104-14109.
20. 2+signaling by ligand stimulated thyroid hormone receptor. J Cell Biol. 2004;167:915-924.
21. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-ki-nase in human fibroblasts. Mol. Endocrinol. 2005;19:102-112.
22. Moeller LC, Dumitrescu AM, Refetoff S. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1a and glycolytic genes. Mol Endocrinol. 2005;19:2955-2963.
23. Verga-Falzacappa C, Petrucci E, Patriarc, V, et al. Thyroid hormone receptor TR/31 mediates Akt activation by T3 in pancreatic β cells. J. Mol. Endocrinol. 2007;38:221-233.
24. Storey NM, Gentile S, Ullah H, et al. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA. 2006;103:5197-5201.
25. Ananthanarayanan B, Ni Q, Zhang J. Signal propagation from membrane messengers to nuclear effectors revealed by reporters of phosphoinositide dynamics and Akt activity. Proc Natl Acad Sci USA. 2005;102:15081-15086.
26. Choi JH, Williams J, Cho J, Falck JR, Shears SB. Purification, sequencing, and molecular identification of a mammalian PP-InsP5 kinase that is activated when cells are exposed to hyperosmotic stress. J Biol Chem. 2007;282:30763-30775.
27. Wang D, Stapleton HM. Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2010;397:1831-1839.
28. Samuels HH, Tsai JS, Cintron R. Thyroid hormone action: a cell-culture system responsive to physiological concentrations of thyroid hormones. Science. 1973;181:1253-1256.
29. Schapira M, Raaka BM, Das S, et al. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc Natl Acad Sci USA. 2003;100:7354-7359.
30. Walker EH, Pacold ME, Perisic O, et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000;6:909-919.
31. Oppenheimer JH. Thyroid hormone action at the cellular level. Science. 1979;203:971-979.
32. Zhu XG, Hanover JA, Hager GL, Cheng SY. Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem. 1998;273:27058-27063.
33. Baumann CT, Maruvada P, Hager GL, Yen PM. Nuclear cytoplasmic shuttling by thyroid hormone receptors. J Biol Chem. 2001; 276:11237-11245.
34. Lin KH, Ashizawa K, Cheng SY. Phosphorylation stimulates the transcriptional activity of the human b1 thyroid hormone nuclear receptor. Proc Natl Acad Sci USA. 1992;89:7737-7741.
35. Pleiman CM, Hertz WM, Cambier JC. Activation of phosphatidyl-inositol-3' kinase by Src-family kinase SH3 binding to the p85 sub-unit. Science. 1994;263:1609-1612.
36. Ptasznik A, Prossnitz ER, Yoshikawa D, Smrcka A, Traynor-Kaplan AE, Bokoch GM. A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3, 4, 5-trisphosphate formation in chemoattractant-stimulated human neutrophils. J Biol Chem. 1996;271:25204-25207.
37. Romzek NC, Harris ES, Dell CL, et al. Use of a β1 integrin-deficient human T cell to identify β1 integrin cytoplasmic domain sequences critical for integrin function. Mol Biol Cell. 1998;9:2715-2727.
38. Rastinejad F, Perlmann T, Evans RM, Sigler PB. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 1995;375:203-211.
39. Machado DS, Sabet A, Santiago LA, et al. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci USA. 2009;106:9441-9446.
40. Abel ED, Moura EG, Ahima RS, et al. Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-β null mice abolishes the regulation of thyrotropin by thyroid hormone. Mol Endocrinol. 2003;17:1767-1776.
41. Malenka MC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44:5-21.
42. Sui L, Wang J, Li BM. Administration of triodo-L-thyronine into dorsal hippocampus alters phosphorylation of Akt, mammalian target of rapamycin, p70S6 kinase and 4E-BP1 in rats. Neurochem Res. 2008;33:1065-1076.
43. Honoré T, Davies SN, Drejer J, et al. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 1988;241:701-703.
44. Schwartzkroin PA, Wester K. Long-lasting facilitation of a synaptic potential following tetanization in the in vitro hippocampal slice. Brain Res. 1975;89:107-119.
45. Moeller LC, Broecker-Preuss M. Transcriptional regulation by non-classical action of thyroid hormone. Thyroid Res. 2011;4:56-62.
46. Umesono K, Evans RM. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell. 1989;57:1139-1146.
47. Lin HY, Zhang S, West BL, et al. Identification of the putative MAP kinase binding site in the thyroid hormone receptor-β1 DNA-bind-ing domain. Biochemistry. 2003;42:7571-7579.
48. Baxter JD, Webb P, Grover G, Scanlan TS. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol Metab. 2004;15:154-157.
49. Gilbert ME. Alterations in synaptic transmission and plasticity in area CA1 of adult hippocampus following developmental hypothyroidism. Brain Res Dev Brain Res. 2004;148:11-18.